Search results
Oct 6, 2021 · Doctors discovered two tumors around his pelvis and wrapped around his organs. The detection came five years after doctors diagnosed Tesh with a rare form of prostate cancer and told him he had...
People also ask
Did John Tesh have prostate cancer?
Is Tesh a cancer survivor?
Is Tesh a cancer-free man?
Mar 26, 2022 · That was followed by androgen deprivation therapy (ADT), a form of hormone replacement therapy. The treatment came with a range of unpleasant side effects, including night sweats, insomnia, weight loss, and fatigue—but Tesh said the biggest toll it took was on his mental health.
Mar 30, 2024 · Cancer vaccine: Provenge, an immunotherapy treatment given over the course of one month, is the first FDA-approved vaccine for metastatic castration-resistant prostate cancer (mCRPC). It helps your immune system attack prostate cancer cells that have been growing and dividing throughout the body.
- Marisa Sullivan
- PARP Inhibitor
- Genetic Testing
- Immunotherapy
In August, the Food and Drug Administration approved Olaparib (brand name LYNPARZA) for individuals not responding to therapy with hormones and diagnosed with metastatic castration-resistant prostate cancer. Lynparza is a PARP inhibitor, a class of drugs that can target and kill poly ADP ribose polymerase (PARP). That is the enzyme that is responsi...
Even in late-stage prostate cancer, genetic testing can provide crucial clues for fighting and treating the disease. One example is next-generation sequencing, a DNA sequencing technology. Next-generation sequencing allows for the sequencing of an entire human genome in a single day and gives crucial clues as to the genetic tendency of the cancer t...
Provenge (also known as Sipuleucel-T) is the only immunotherapy vaccine to receive FDA approval to treat late-stage prostate cancer. These drugs utilize a patient's immune system to attack cancer cells. It is most often used to treat men who have early metastasis but are not responding to androgen deprivation therapy. “They take those white blood c...
Oct 5, 2021 · After Tesh went in for scans, he learned his cancer had returned, five years after he was first diagnosed with a rare form of prostate cancer. Back then, doctors told him he had 18 months to...
- Stephanie Emma Pfeffer
- 2 min
Oct 6, 2021 · With the help and support of his wife — whom, Tesh said, became so educated in the treatment of cancer that physicians thought she had a medical background — he beat the often fatal disease ...
Feb 22, 2020 · In 2015, John Tesh was diagnosed with a rare form of prostate cancer and given 18 months to live. Now 67 and healthy, he details his fight in a new memoir.
